Search Results - "Cabel, Luc"

ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics by Kiavue, Nicolas, Cabel, Luc, Melaabi, Samia, Bataillon, Guillaume, Callens, Celine, Lerebours, Florence, Pierga, Jean-Yves, Bidard, Francois-Clement

“…HER3, a member of the EGFR family of receptor tyrosine kinases coded by the ERBB3 gene, plays an important role in cancer, despite its lack of intrinsic kinase…”
Get full text

Circulating tumor cells: clinical validity and utility by Cabel, Luc, Proudhon, Charlotte, Gortais, Hugo, Loirat, Delphine, Coussy, Florence, Pierga, Jean-Yves, Bidard, François-Clément

“…Circulating tumor cells (CTCs) are rare tumor cells and have been investigated as diagnostic, prognostic and predictive biomarkers in many types of cancer…”
Get full text

Clinical utility of circulating tumor cells: an update by Vasseur, Antoine, Kiavue, Nicolas, Bidard, François‐Clément, Pierga, Jean‐Yves, Cabel, Luc

“…The prognostic role of circulating tumor cells (CTCs) has been clearly demonstrated in many types of cancer. However, their roles in diagnostic and treatment…”
Get full text

Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial by Cabel, Luc, Berger, Frédérique, Cottu, Paul, Loirat, Delphine, Rampanou, Aurore, Brain, Etienne, Cyrille, Stacy, Bourgeois, Hugues, Kiavue, Nicolas, Deluche, Elise, Ladoire, Sylvain, Campone, Mario, Pierga, Jean-Yves, Bidard, Francois-Clement

“…Background CirCe01 trial aimed to assess the clinical utility of circulating tumour cell (CTC)-based monitoring in metastatic breast cancer (MBC) patients…”
Get full text

COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area by Vuagnat, Perrine, Frelaut, Maxime, Ramtohul, Toulsie, Basse, Clémence, Diakite, Sarah, Noret, Aurélien, Bellesoeur, Audrey, Servois, Vincent, Hequet, Delphine, Laas, Enora, Kirova, Youlia, Cabel, Luc, Pierga, Jean-Yves, Bozec, Laurence, Paoletti, Xavier, Cottu, Paul, Bidard, François-Clément

“…Cancer patients have been reported to be at higher risk of COVID-19 complications and deaths. We report the characteristics and outcome of patients diagnosed…”
Get full text

A single droplet digital PCR for ESR1 activating mutations detection in plasma by Jeannot, Emmanuelle, Darrigues, Lauren, Michel, Marc, Stern, Marc-Henri, Pierga, Jean-Yves, Rampanou, Aurore, Melaabi, Samia, Benoist, Camille, Bièche, Ivan, Vincent-Salomon, Anne, El Ayachy, Radouane, Noret, Aurélien, Epaillard, Nicolas, Cabel, Luc, Bidard, François-Clément, Proudhon, Charlotte

“…Activating mutations in the estrogen receptor 1 ( ESR1 ) gene confer resistance to aromatase inhibitors (AI), and may be targeted by selective estrogen…”
Get full text

Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients by Darrigues, Lauren, Pierga, Jean-Yves, Bernard-Tessier, Alice, Bièche, Ivan, Silveira, Amanda Bartolini, Michel, Marc, Loirat, Delphine, Cottu, Paul, Cabel, Luc, Dubot, Coraline, Geiss, Romain, Ricci, Francesco, Vincent-Salomon, Anne, Proudhon, Charlotte, Bidard, François-Clément

“…Following the PALOMA-3 study results, the combination of palbociclib, a CDK4/6 inhibitor, with fulvestrant, a selective estrogen receptor degrader, has become…”
Get full text

Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma by Cabel, Luc, Jeannot, Emmanuelle, Bieche, Ivan, Vacher, Sophie, Callens, Celine, Bazire, Louis, Morel, Adeline, Bernard-Tessier, Alice, Chemlali, Walid, Schnitzler, Anne, Lièvre, Astrid, Otz, Joelle, Minsat, Mathieu, Vincent-Salomon, Anne, Pierga, Jean-Yves, Buecher, Bruno, Mariani, Pascale, Proudhon, Charlotte, Bidard, François-Clément, Cacheux, Wulfran

“…Chemoradiotherapy (CRT) is the current standard of care for patients diagnosed with locally advanced anal squamous cell carcinoma (ASCC), but some patients…”
Get full text

Dimethyl Fumarate Controls the NRF2/DJ-1 Axis in Cancer Cells: Therapeutic Applications by Saidu, Nathaniel Edward Bennett, Noé, Gaëlle, Cerles, Olivier, Cabel, Luc, Kavian-Tessler, Niloufar, Chouzenoux, Sandrine, Bahuaud, Mathilde, Chéreau, Christiane, Nicco, Carole, Leroy, Karen, Borghese, Bruno, Goldwasser, François, Batteux, Frédéric, Alexandre, Jérôme

“…The transcription factor NRF2 (NFE2L2), regulates important antioxidant and cytoprotective genes. It enhances cancer cell proliferation and promotes…”
Get full text

Circulating Tumor Cells in Early Breast Cancer by Thery, Laura, Meddis, Alessandra, Cabel, Luc, Proudhon, Charlotte, Latouche, Aurelien, Pierga, Jean-Yves, Bidard, Francois-Clement

“…Circulating tumor cells (CTCs) are particularly rare in non-metastatic breast cancer, and the clinical validity of CTC detection in that clinical setting was…”
Get full text

Plasma thymidine kinase 1 activity and outcome of ER+ HER2- metastatic breast cancer patients treated with palbociclib and endocrine therapy by Cabel, Luc, Rosenblum, Dan, Lerebours, Florence, Brain, Etienne, Loirat, Delphine, Bergqvist, Mattias, Cottu, Paul, Donnadieu, Anne, Bethune, Anne, Kiavue, Nicolas, Rodrigues, Manuel, Pierga, Jean-Yves, Tanguy, Marie-Laure, Bidard, François-Clément

“…Previous cohort studies have reported plasma TK1 activity (pTKa) as a potential prognostic biomarker in estrogen receptor-positive (ER+) HER2-negative (HER2-)…”
Get full text

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial by Bidard, François-Clément, Kiavue, Nicolas, Ychou, Marc, Cabel, Luc, Stern, Marc-Henri, Madic, Jordan, Saliou, Adrien, Rampanou, Aurore, Decraene, Charles, Bouché, Olivier, Rivoire, Michel, Ghiringhelli, François, Francois, Eric, Guimbaud, Rosine, Mineur, Laurent, Khemissa-Akouz, Faiza, Mazard, Thibault, Moussata, Driffa, Proudhon, Charlotte, Pierga, Jean-Yves, Stanbury, Trevor, Thézenas, Simon, Mariani, Pascale

“…The management of patients with colorectal cancer (CRC) and potentially resectable liver metastases (LM) requires quick assessment of mutational status and of…”
Get full text

Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study by Vasseur, Antoine, Carton, Matthieu, Guiu, Severine, Augereau, Paule, Uwer, Lionel, Mouret-Reynier, Marie-Ange, Levy, Christelle, Eymard, Jean-Christophe, Ferrero, Jean-Marc, Leheurteur, Marianne, Goncalves, Anthony, Robert, Marie, De La Motte Rouge, Thibault, Bachelot, Thomas, Petit, Thierry, Debled, Marc, Grinda, Thomas, Desmoulins, Isabelle, Vanlemmens, Laurence, Nicolaï, Vincent, Simon, Gaëtane, Cabel, Luc

“…Taxanes are one of the most effective chemotherapies (CT) in breast cancer (BC), but the efficacy of taxanes rechallenge in early metastatic relapse has been…”
Get full text

Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study by Alhenc-Gelas, Marion, Cabel, Luc, Berger, Frederique, Delaloge, Suzette, Frenel, Jean-Sebastien, Levy, Christelle, Firmin, Nelly, Ladoire, Sylvain, Desmoulins, Isabelle, Heudel, Pierre-Etienne, Dalenc, Florence, Loirat, Delphine, Dubot, Coraline, Vuagnat, Perrine, Deluche, Elise, Mokdad-Adi, Meriem, Patsouris, Anne, Annic, Josselin, Djerroudi, Lounes, Lavigne, Marion, Pierga, Jean-Yves, Coppo, Paul, Bidard, Francois-Clement

“…Cancer-related microangiopathic haemolytic anaemia (MAHA) is a rare but life-threatening paraneoplastic syndrome. Only single cases or small series have been…”
Get full text

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients by Cabel, Luc, Loir, Elika, Gravis, Gwenaelle, Lavaud, Pernelle, Massard, Christophe, Albiges, Laurence, Baciarello, Giulia, Loriot, Yohann, Fizazi, Karim

“…Prostate cancer is one of the most common cancers in men and the fourth leading cause of cancer mortality worldwide. Although major progress has been achieved…”
Get full text

Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study by Ramtohul, Toulsie, Cabel, Luc, Paoletti, Xavier, Chiche, Laurent, Moreau, Pauline, Noret, Aurélien, Vuagnat, Perrine, Cherel, Pascal, Tardivon, Anne, Cottu, Paul, Bidard, François-Clément, Servois, Vincent

“…CT lung extent has emerged as a potential risk factor of COVID-19 pneumonia severity with mainly semiquantitative assessment, and outcome was not assessed in…”
Get full text

Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET) by Vasseur, Antoine, Cabel, Luc, Tredan, Olivier, Chevrier, Marion, Dubot, Coraline, Lorgis, Véronique, Jacot, William, Goncalves, Anthony, Debled, Marc, Levy, Christelle, Ferrero, Jean-Marc, Jouannaud, Christelle, Luporsi, Elisabeth, Mouret-Reynier, Marie-Ange, Dalenc, Florence, Lemonnier, Jerome, Savignoni, Alexia, Tanguy, Marie-Laure, Bidard, Francois-Clement, Pierga, Jean-Yves

“…Background Proof of concept studies has reported that circulating endothelial cell (CEC) count may be associated with the outcome of HER2-negative metastatic…”
Get full text

Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database by Carausu, Marcela, Carton, Matthieu, Cabel, Luc, Patsouris, Anne, Levy, Christelle, Verret, Benjamin, Pasquier, David, Debled, Marc, Gonçalves, Anthony, Desmoulins, Isabelle, Lecouillard, Isabelle, Bachelot, Thomas, Ferrero, Jean-Marc, Eymard, Jean-Christophe, Mouret-Reynier, Marie-Ange, Chevrot, Michaël, De Maio, Eleonora, Uwer, Lionel, Frenel, Jean-Sébastien, Leheurteur, Marianne, Petit, Thierry, Darlix, Amélie, Bozec, Laurence

“…Background: As a result of progress in diagnosis and treatment, there is a growing prevalence of metastatic breast cancer (MBC) with isolated CNS metastases…”
Get full text

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies by Lang, Hervé, Béraud, Claire, Cabel, Luc, Fontugne, Jacqueline, Lassalle, Myriam, Krucker, Clémentine, Dufour, Florent, Groeneveld, Clarice S., Dixon, Victoria, Meng, Xiangyu, Kamoun, Aurélie, Chapeaublanc, Elodie, De Reynies, Aurélien, Gamé, Xavier, Rischmann, Pascal, Bieche, Ivan, Masliah-Planchon, Julien, Beaurepere, Romane, Allory, Yves, Lindner, Véronique, Misseri, Yolande, Radvanyi, François, Lluel, Philippe, Bernard-Pierrot, Isabelle, Massfelder, Thierry

“…Background Muscle-invasive bladder cancer (MIBC) and upper urinary tract urothelial carcinoma (UTUC) are molecularly heterogeneous. Despite chemotherapies,…”
Get full text

ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast Cancer by Carausu, Marcela, Melaabi, Samia, Pierga, Jean-Yves, Bidard, François-Clément, Cabel, Luc

“…mutation is frequently encountered in hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC),…”
Get full text